| # | Drug | Count |
|---|---|---|
| 0 | ASPIRIN | 76 |
| 1 | FINASTERIDE | 75 |
| 2 | ASPIRIN 325 MG | 74 |
| 3 | ASPIRIN 81 MG | 74 |
| 4 | METHOTREXATE SODIUM | 71 |
| 5 | PREDNISONE | 67 |
| 6 | FUROSEMIDE | 66 |
| 7 | RITUXIMAB | 65 |
| 8 | ALLOPURINOL | 62 |
| 9 | METHOTREXATE | 60 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | PHENOXYBENZAMINE HYDROCHLORIDE | 1 | 0.0370 |
| 1 | EYE HEALTH CAPSULE | 1 | 0.0125 |
| 2 | FLAVOXATE HYDROCHLORIDE | 1 | 0.0099 |
| 3 | TETRACAINE HYDROCHLORIDE | 1 | 0.0075 |
| 4 | INFLIXIMAB-DYYB | 14 | 0.0041 |
| 5 | BENZOCAINE AND DEXTROMETHORPHAN HYDROBROMIDE | 1 | 0.0040 |
| 6 | BENZOCAINE AND MENTHOL | 1 | 0.0038 |
| 7 | PSYLLIUM HUSK | 4 | 0.0030 |
| 8 | PALIFERMIN | 1 | 0.0026 |
| 9 | SPESOLIMAB | 1 | 0.0025 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 198 |
| 1 | Nonsteroidal Anti-inflammatory Drug [EPC] | 148 |
| 2 | Tumor Necrosis Factor Blocker [EPC] | 115 |
| 3 | CD20-directed Cytolytic Antibody [EPC] | 90 |
| 4 | 5-alpha Reductase Inhibitor [EPC] | 80 |
| 5 | Platelet Aggregation Inhibitor [EPC] | 80 |
| 6 | Proton Pump Inhibitor [EPC] | 78 |
| 7 | Loop Diuretic [EPC] | 68 |
| 8 | Folate Analog Metabolic Inhibitor [EPC] | 63 |
| 9 | Xanthine Oxidase Inhibitor [EPC] | 63 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Amino Acid Hypertonic Solution [EPC] | 1 | 0.0063 |
| 1 | Interleukin-5 Antagonist [EPC] | 4 | 0.0058 |
| 2 | Mucocutaneous Epithelial Cell Growth Factor [EPC] | 1 | 0.0026 |
| 3 | Interleukin-36 Receptor Antagonist [EPC] | 1 | 0.0025 |
| 4 | Guanylate Cyclase-C Agonist [EPC] | 4 | 0.0019 |
| 5 | Live Attenuated Bacillus Calmette-Guerin Immunotherapy [EPC] | 2 | 0.0011 |
| 6 | Neonatal Fc Receptor Blocker [EPC] | 4 | 0.0009 |
| 7 | Benzothiazole [EPC] | 2 | 0.0009 |
| 8 | Lymphocyte Growth Factor [EPC] | 1 | 0.0008 |
| 9 | 5-alpha Reductase Inhibitor [EPC] | 80 | 0.0008 |